Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Amyotrophic Lateral Sclerosis Clinical Trials Market Report Overview
The Amyotrophic Lateral Sclerosis clinical trial market research report provides an overview of the Amyotrophic Lateral Sclerosis clinical trials scenario. The report provides top-line data relating to the clinical trials on Amyotrophic Lateral Sclerosis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Key Regions | North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America |
Key Countries | The US, Italy, Japan, the UK, France, Germany, Canada, Netherlands, Australia, and Belgium |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | Mitsubishi Chemical Group Corp, Biogen Inc, Cytokinetics Inc, Sanofi, F. Hoffmann-La Roche Ltd, Knopp Biosciences LLC, Amylyx Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, AB Science SA, and GSK plc |
Amyotrophic Lateral Sclerosis Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Amyotrophic Lateral Sclerosis clinical trials market are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America among others. As of April 2023, the majority of the clinical trials were conducted in North America, followed by Europe and APAC.
The US, Italy, Japan, the UK, France, Germany, Canada, Netherlands, Australia, and Belgium are the key countries in the Amyotrophic Lateral Sclerosis clinical trials market. In the country-wise analysis, the US has the highest number of Amyotrophic Lateral Sclerosis clinical trials, as of April 2023, followed by Italy and Japan.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Italy has the highest proportion of Amyotrophic Lateral Sclerosis to Central Nervous System clinical trials as of April 2023.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Mexico has the highest proportion of Amyotrophic Lateral Sclerosis to Central Nervous System clinical trials as of April 2023.
Amyotrophic Lateral Sclerosis Clinical Trials Analysis by Regions, 2023 (%)For more regional insights into the Amyotrophic Lateral Sclerosis clinical trials market, download a free report sample
Amyotrophic Lateral Sclerosis Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Amyotrophic Lateral Sclerosis clinical trials market are institution, company, and the government. Out of them, the company sponsor type dominates the market.
Amyotrophic Lateral Sclerosis Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the Amyotrophic Lateral Sclerosis clinical trials market, download a free report sample
Amyotrophic Lateral Sclerosis Clinical Trials Market - Competitive Landscape
The leading sponsors in the Amyotrophic Lateral Sclerosis clinical trials market are Mitsubishi Chemical Group Corp, Biogen Inc, Cytokinetics Inc, Sanofi, F. Hoffmann-La Roche Ltd, Knopp Biosciences LLC, Amylyx Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, AB Science SA, and GSK plc among others. As of April 2023, Mitsubishi Chemical Group Corp sponsored the highest number of Amyotrophic Lateral Sclerosis trials.
Amyotrophic Lateral Sclerosis Clinical Trials Market Analysis by Sponsors, 2023 (%)To know more about the leading players in the Amyotrophic Lateral Sclerosis clinical trials market, download a free report sample
Segments Covered in the Report
Amyotrophic Lateral Sclerosis Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- North America
- Europe
- Middle East & Africa
- South & Central America
Amyotrophic Lateral Sclerosis Clinical Trials Country Outlook (2023)
- The US
- China
- The UK
- Germany
- France
- Spain
Amyotrophic Lateral Sclerosis Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reasons for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies regarding investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Biogen Inc
Cytokinetics Inc
Sanofi
F. Hoffmann-La Roche Ltd
Knopp Biosciences LLC
Amylyx Pharmaceuticals Inc
Teva Pharmaceutical Industries Ltd
AB Science SA
GSK plc
Table of Contents
Table
Figures
Frequently asked questions
-
Which was the dominant region in the Amyotrophic Lateral Sclerosis clinical trials market?
As of April 2023, North America was dominant region in the Amyotrophic Lateral Sclerosis clinical trials market.
-
Which country led the Amyotrophic Lateral Sclerosis clinical trials market?
As of April 2023, the US led the Amyotrophic Lateral Sclerosis clinical trials market.
-
Which sponsor type accounted for the highest share in the Amyotrophic Lateral Sclerosis clinical trials market?
The company sponsor type accounted for the highest share in the Amyotrophic Lateral Sclerosis clinical trials market.
-
Who is the leading sponsor with the highest number of Amyotrophic Lateral Sclerosis clinical trials?
As of April 2023, Mitsubishi Chemical Group Corp has the highest number of Amyotrophic Lateral Sclerosis clinical trials.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.